Genmab A/S S/Adr

(GMXAY)

By |

Profile

Genmab A/S is an antibody company focused on cancer. Its first marketed product is Arzerra (ofatumumab); development pipeline incl. daratumumab and two proprietary technology platforms; DuoBody (bispecifics) & HexaBody (effector function enhancement).

Contact Information

Website: www.genmab.com
Main Phone: +45 70202728
Address: Bredgade 34E
City / Town: Copenhagen K
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 189
$ 108.97 $ 0. (0.00%)
Last Price 108.97 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 108.97
Last Trade Volume 0 52 Wk Hi 111.41 52 Wk Low 74.51
Market Cap 13.3 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 121,710,476.00 EPS (TTM) 1.39 PE Ratio 80.00 Exchange OTCPK